Translation of "Ligne qui a supporté la dépense initiale " (French → English) :

In accordance with Article 18(1)(e) of the Financial Regulation, this revenue is to be considered as assigned revenue and gives rise to the entry of additional appropriations against the headings which bore the initial expenditure giving rise to the corresponding revenue.

The other side of this is that historically we've had a very clear recognition for the peculiarities or the uniqueness of resource developments, which take place over a very long timeframe in terms of upfront expenditures to simply find the resource, the costs that have to be dedicated to environmental assessment, feasibility studies, the fact that we do not control the price of our product at the end of the day, as we sell it in an international marketplace.We have a small domestic market, so most of it goes outside the country.

(a) replacing line 10 on page 8 with the following: “expense incurred by her in relation to” (b) replacing line 13 on page 8 with the following: “ture referred to in paragraph (1)(a) or (b) unless a” After debate, the question being put on the amendment and the result of the recorded vote was announced:

COUNCIL RESOLUTION DESIGNED TO IMPLEMENT THE OUTLINES OF AN INDUSTRIAL POLICY IN THE PHARMACEUTICAL SECTOR IN THE EUROPEAN UNION THE COUNCIL Having regard to the Commission communication of 14 September 1994 entitled "An industrial competitiveness policy for the European Union"; Recalling its Resolution of 21 November 1994 on strengthening the competitiveness of Community industry [10] , and its conclusions of 7 April 1995 on an industrial competitiveness policy; Having regard to the communication of 2 March 1994 from the Commission to the Council and the European Parliament on the outlines of an industrial policy for the pharmaceutica ...[+++]l sector in the European Union; Whereas the European Union has an important role to play in creating a favourable environment for the expansion of activities relating to research, development, production and distribution of medicinal products and in encouraging the development of an innovative and effective European pharmaceutical industry in terms of competitiveness on the world market; Whereas European industrial policy must necessarily take account of the special nature of this sector, which relates both to public health and to social policy; whereas social security systems bear a considerable proportion of pharmaceutical expenditure; whereas this is a matter which falls within the competence of the Member States; Whereas the European Union has the responsibility of sketching out guidelines for the promotion of Community activities in this sector, HAS ADOPTED THIS RESOLUTION: I. WITH RESPECT TO THE SITUATION IN THE PHARMACEUTICAL INDUSTRY 1. recalls that the European pharmaceutical industry plays an essential role in public health, remains a high-technology industry with considerable added value, which is particularly successful, generates highly skilled jobs and makes a significant contribution to the Union's balance of trade; 2. considers that, now that it is facing increasingly intense international competition, the Euro ...

With this decision, the Council has endorsed the principles underlying the Commission's original proposals : - that of ensuring consistency with the approach defined at the last European Council, held in Brussels, when the need for a restrictive policy on pricing and the markets was confirmed, - that of compliance with the financial constraints deriving from the concept of "budgetary discipline", approved on the same occasion, with regard to the future trend in farm expenditure.

Eligible costs during the period of market introduction (part II of the programme) are : . external technical consultancy services which might help to solve problems arising out of production or marketing during this first period, . consultants, one-off training, general market research and information, visibility studies.